BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peterson TC, Peterson MR, Raoul JM. The effect of pentoxifylline and its metabolite-1 on inflammation and fibrosis in the TNBS model of colitis. Eur J Pharmacol. 2011;662:47-54. [PMID: 21554874 DOI: 10.1016/j.ejphar.2011.04.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Fukuta K, Shirakami Y, Maruta A, Obara K, Iritani S, Nakamura N, Kochi T, Kubota M, Sakai H, Tanaka T, Shimizu M. Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice. Int J Mol Sci 2017;18:E413. [PMID: 28212276 DOI: 10.3390/ijms18020413] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Eissa N, Hussein H, Kermarrec L, Grover J, Metz-Boutigue ME, Bernstein CN, Ghia JE. Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated Macrophages. Front Immunol. 2017;8:1131. [PMID: 28951733 DOI: 10.3389/fimmu.2017.01131] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
3 Segnani C, Ippolito C, Antonioli L, Pellegrini C, Blandizzi C, Dolfi A, Bernardini N. Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon. PLoS One. 2015;10:e0144630. [PMID: 26673752 DOI: 10.1371/journal.pone.0144630] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 8.4] [Reference Citation Analysis]
4 Mazur M, Zielińska A, Grzybowski MM, Olczak J, Fichna J. Chitinases and Chitinase-Like Proteins as Therapeutic Targets in Inflammatory Diseases, with a Special Focus on Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:6966. [PMID: 34203467 DOI: 10.3390/ijms22136966] [Reference Citation Analysis]
5 Li JH, Zhou W. P38 mitogen-activated protein kinase inhibitor SB203580 promotes peripheral blood lymphocyte apoptosis in rats with colitis. Shijie Huaren Xiaohua Zazhi 2014; 22(5): 668-673 [DOI: 10.11569/wcjd.v22.i5.668] [Reference Citation Analysis]
6 Yang H, Yue GGL, Leung PC, Wong CK, Lau CBS. A review on the molecular mechanisms, the therapeutic treatment including the potential of herbs and natural products, and target prediction of obesity-associated colorectal cancer. Pharmacol Res 2021;175:106031. [PMID: 34896542 DOI: 10.1016/j.phrs.2021.106031] [Reference Citation Analysis]
7 Badawi GA, Shokr MM, Zaki HF, Mohamed AF. Pentoxifylline prevents epileptic seizure via modulating HMGB1/RAGE/TLR4 signalling pathway and improves memory in pentylenetetrazol kindling rats. Clin Exp Pharmacol Physiol 2021;48:1111-24. [PMID: 33899956 DOI: 10.1111/1440-1681.13508] [Reference Citation Analysis]
8 El-haggar SM, Hegazy SK, Abd-elsalam SM, Elkaeed EB, Al-karmalawy AA, Bahaa MM. A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial. JIR 2022;Volume 15:1159-72. [DOI: 10.2147/jir.s346608] [Reference Citation Analysis]
9 Gruber S, Schmidt M, Bozsaky E, Wolfram K, Haagen J, Habelt B, Puttrich M, Dörr W. Modulation of radiation-induced oral mucositis by pentoxifylline: Preclinical studies. Strahlenther Onkol 2015;191:242-7. [DOI: 10.1007/s00066-014-0775-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
10 El-Haggar SM, Hegazy SK, Abd-Elsalam SM, Bahaa MM. Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine. Biomed Pharmacother 2022;145:112399. [PMID: 34775240 DOI: 10.1016/j.biopha.2021.112399] [Reference Citation Analysis]
11 Rieder F, Kessler S, Sans M, Fiocchi C. Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease. Am J Physiol Gastrointest Liver Physiol. 2012;303:G786-G801. [PMID: 22878121 DOI: 10.1152/ajpgi.00059.2012] [Cited by in Crossref: 82] [Cited by in F6Publishing: 82] [Article Influence: 8.2] [Reference Citation Analysis]
12 Shirakami Y, Kochi T, Kubota M, Sakai H, Ibuka T, Yoshimi K, Kuramoto T, Tanaka T, Shimizu M, Seishima M. Inhibitory effects of pentoxifylline on inflammation-related tumorigenesis in rat colon. Oncotarget 2018;9:33972-81. [PMID: 30338039 DOI: 10.18632/oncotarget.26119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Lee IA, Kamba A, Low D, Mizoguchi E. Novel methylxanthine derivative-mediated anti-inflammatory effects in inflammatory bowel disease. World J Gastroenterol 2014; 20(5): 1127-1138 [PMID: 24574789 DOI: 10.3748/wjg.v20.i5.1127] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
14 Baumgart DC, Müller HP, Grittner U, Metzke D, Fischer A, Guckelberger O, Pascher A, Sack I, Vieth M, Rudolph B. US-based Real-time Elastography for the Detection of Fibrotic Gut Tissue in Patients with Stricturing Crohn Disease. Radiology. 2015;275:889-899. [PMID: 25668520 DOI: 10.1148/radiol.14141929] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 10.4] [Reference Citation Analysis]